Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Mangalam Drugs & Organics Ltd. ( (IN:MANGALAM) ) is now available.
Mangalam Drugs & Organics Ltd. has issued a corrigendum to its 52nd Annual Report, amending certain sections to include recent circulars from the Ministry of Corporate Affairs and the Securities and Exchange Board of India. These updates pertain to the conduct of Annual General Meetings through video conferencing and the extension of relaxations for printing and dispatching physical copies of annual reports, reflecting the company’s compliance with regulatory requirements.
More about Mangalam Drugs & Organics Ltd.
Mangalam Drugs & Organics Ltd. operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and other chemical products. The company is based in Mumbai, India, with a manufacturing facility in Vapi, Gujarat.
Average Trading Volume: 5,792
Technical Sentiment Signal: Sell
Current Market Cap: 1.19B INR
Find detailed analytics on MANGALAM stock on TipRanks’ Stock Analysis page.